Is NASDAQ:ALKS suited for growth investing?

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if ALKERMES PLC (NASDAQ:ALKS) is suited for growth investing. Investors should of course do their own research, but we spotted ALKERMES PLC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Some of the growth metrics of NASDAQ:ALKS highlighted

• The Return on Equity(ROE) of ALKERMES PLC is 29.59%, which is a strong number. This indicates the company's ability to generate favorable returns for shareholders and reflects its effective management of resources.
• ALKERMES PLC has exceeded EPS estimates 3 times in the last 4 quarters, demonstrating its ability to outperform market expectations. This trend highlights the company's strong financial performance and its potential for future growth.
• With notable 1-year revenue growth of 49.61%, ALKERMES PLC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
• The recent q2q revenue growth of 23.88% of ALKERMES PLC showcases the company's ability to generate increasing revenue in a short period, reflecting its positive growth trajectory.
• With positive growth in its operating margin over the past year, ALKERMES PLC showcases its ability to improve profitability through effective cost control and operational efficiency. This growth underscores the company's commitment to enhancing its financial performance.
• With positive growth in its free cash flow (FCF) over the past year, ALKERMES PLC showcases its ability to generate strong cash flows and maintain a solid financial position. This growth reflects the company's efficient utilization of capital and its commitment to long-term value creation.
• In the most recent financial report, ALKERMES PLC reported a 57.14% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
• Over the past 3 months, analysts have adjusted their EPS Estimate for ALKERMES PLC with a 28.39% change. This highlights the evolving outlook on the company's EPS potential.
• The recent financial report of ALKERMES PLC demonstrates a 57.14% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
• accelerating EPS growth for ALKERMES PLC: the current Q2Q growth of 57.14% exceeds the previous year Q2Q growth of -39.13%.

A complete fundamental analysis of NASDAQ:ALKS

ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.

Overall ALKS gets a fundamental rating of 6 out of 10. We evaluated ALKS against 594 industry peers in the Biotechnology industry. While ALKS has a great health rating, its profitability is only average at the moment. ALKS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ALKS could be worth investigating further for value investing!.

For an up to date full fundamental analysis you can check the fundamental report of ALKS

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.